Teleflex Incorporated $TFX Shares Sold by Amalgamated Bank

Amalgamated Bank decreased its position in Teleflex Incorporated (NYSE:TFX) by 4.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 13,431 shares of the medical technology company’s stock after selling 615 shares during the period. Amalgamated Bank’s holdings in Teleflex were worth $1,590,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of TFX. Thurston Springer Miller Herd & Titak Inc. grew its holdings in Teleflex by 242.9% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 153 shares during the last quarter. Banque Cantonale Vaudoise acquired a new stake in Teleflex in the first quarter valued at $27,000. Costello Asset Management INC acquired a new stake in Teleflex in the first quarter valued at $28,000. Brooklyn Investment Group grew its holdings in Teleflex by 258.6% in the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 150 shares during the last quarter. Finally, Allworth Financial LP grew its holdings in Teleflex by 504.8% in the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 212 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Up 0.4%

Shares of NYSE:TFX opened at $124.86 on Thursday. The stock’s 50-day moving average price is $126.36 and its two-hundred day moving average price is $123.37. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. Teleflex Incorporated has a 12-month low of $108.90 and a 12-month high of $208.27. The firm has a market cap of $5.52 billion, a price-to-earnings ratio of 29.38, a PEG ratio of 1.79 and a beta of 1.05.

Wall Street Analyst Weigh In

Several analysts have weighed in on TFX shares. Zacks Research lowered Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Teleflex in a research note on Wednesday, October 8th. Royal Bank Of Canada increased their price objective on Teleflex from $130.00 to $135.00 and gave the company a “sector perform” rating in a research note on Friday, August 1st. Mizuho increased their price objective on Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a research note on Friday, August 1st. Finally, Wells Fargo & Company decreased their price objective on Teleflex from $137.00 to $131.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Reduce” and an average target price of $141.57.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.